Financhill
Back

Perspective Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

CATX
Perspective Therapeutics, Inc.

Last Price:
$5.3500
Seasonality Move:
10.42%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Perspective Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.42 Sell
20-day SMA: 5.04 Buy
50-day SMA: 3.66 Buy
200-day SMA: 3.35 Buy
8-day EMA: 5.31 Buy
20-day EMA: 4.87 Buy
50-day EMA: 4.04 Buy
200-day EMA: 3.71 Buy

Perspective Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.54 Buy
Relative Strength Index (14 RSI): 62.25 Buy
Chaikin Money Flow: 1777808 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.668 - 5.588) Buy
Bollinger Bands (100): (2.1359 - 4.3559) Buy

Perspective Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Perspective Therapeutics, Inc. Stock

Is Perspective Therapeutics, Inc. Stock a Buy?

CATX Technical Analysis vs Fundamental Analysis

Buy
62
Perspective Therapeutics, Inc. (CATX) is a Buy

Is Perspective Therapeutics, Inc. a Buy or a Sell?

Perspective Therapeutics, Inc. Stock Info

Market Cap:
615.1M
Price in USD:
5.4000
Share Volume:
2M

Perspective Therapeutics, Inc. 52-Week Range

52-Week High:
6.1600
52-Week Low:
1.6000
Buy
62
Perspective Therapeutics, Inc. (CATX) is a Buy

Perspective Therapeutics, Inc. Share Price Forecast

Is Perspective Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Perspective Therapeutics, Inc.

Is Perspective Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.19 per share.

Technical Analysis of Perspective Therapeutics, Inc.

Should I short Perspective Therapeutics, Inc. stock?

* Perspective Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.